|
MRI News Service:
'Clinical Trial' p5 |
|
|
|
 |
 | | | '''PHILADELPHIA – In the first clinical trial of its kind, researchers at the University of Pennsylvania School of Medicine and the Abramson Cancer Center will lead a nationwide test of anti-cancer drug combinations that target blood vessel growth in ...' | | Wednesday, 3 October 2007 by cancerfocus.net |
|
|
|
| | | '''Unique pacemaker and lead features could enable hundreds of thousands of
people worldwide to get MRI scans even with an implanted cardiac device.
MISSISSAUGA, ON, June 18 /CNW/ - Physicians at Royal Jubilee Hospital in
Victoria, ...' | | | Monday, 18 June 2007 by www.newswire.ca | |
|
|
|
| | | '''Alzheimer’s disease researchers may be able to reduce the time and expense associated with clinical trials, according to early results from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private research partnership organized by the ...' | | | Tuesday, 12 June 2007 by www.eurekalert.org | |
|
|
|
| | | '''CHICAGO and SUNNYVALE, Calif., June 3 /PRNewswire-FirstCall/ --
Pharmacyclics, Inc. (Nasdaq: PCYC) today announced final results from an
open-label multi-center Phase 2 clinical trial, which indicated that
Xcytrin(R) (motexafin gadolinium) ...' | | | Sunday, 3 June 2007 by www.prnewswire.com | |
|
|
|
| | | '''SUNNYVALE, Calif., Nov 09, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced the presentation of preliminary results of an open-label multi-center Phase 2 clinical trial, which suggest that ...' | | | Thursday, 9 November 2006 by ir.pharmacyclics.com | |
|
|
|
| | | '''TEL AVIV, Israel, July 6 /PRNewswire-FirstCall/ -- TopSpin Medical (TASE: TOPMD) announced it has received FDA approval to start conducting clinical trials in the US with its IntraVascular MRI (IVMRI) catheter, intended for the characterization of ...' | | | Thursday, 6 July 2006 by www.biospace.com | |
|
|
|
| | | '''SUNNYVALE, Calif., Dec 19, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced top-line results from its pivotal Phase 3 clinical study of Xcytrin(R) (motexafin gadolinium) Injection, for the ...' | | | Monday, 19 December 2005 by www.prnewswire.com | |
|
|
|
| | | '''Non-invasive imaging may help predict type 1 diabetes and response to treatment in humans: Joslin recruiting for new Imaging in Diabetes Clinical Trial
BOSTON - A key obstacle to early detection of type 1 diabetes - as well as to rapid assessment of ...' | | | Thursday, 18 August 2005 by www.eurekalert.org | |
|
|
|
| | | '''Researchers at Johns Hopkins have begun what is believed to be the first clinical trial in the United States of adult mesenchymal stem cells to repair muscle damaged by heart attack, or myocardial infarct. The so-called Phase I study is designed to ...' | | | Friday, 1 April 2005 by www.sciencedaily.com | |
|
|
|
| | | '''Results from a Phase 3 clinical trial entitled 'AVANCE' revealed promising clinical outcomes in patients with relapsing-remitting multiple sclerosis treated for one year with peg interferon beta-1a. The analysis was published in the journal BMC ...' | | | by multiplesclerosisnewstoday.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
We've heard that a million monkeys at a million keyboards could produce
the complete works of Shakespeare; now, thanks to the Internet, we know
that is not true.
- Robert Wilensky |
|
|
News
top
